Background

Joshua Dawe is an early career public health researcher, with interests in epidemiology and biostatistics.

Joshua joined Burnet in 2019 in the Disease Elimination program. He primarily works in the monitoring and evaluation team for Eliminate Hepatitis C Australia, providing data analysis and operational support for project partners.

Qualifications

• 2016: Bachelor of Commerce (Hons), La Trobe University, Melbourne, Australia
• 2019: Master of Public Health, University of Melbourne, Melbourne, Australia

Awards

• 2016: 1st Class Honours (La Trobe University)

Projects (2)

Current (2)

• 

  EC Australia: Eliminate Hepatitis C Australia Partnership

• 

  The Optimise Study: Optimising Isolation, Quarantine and Distancing for COVID-19

Publications (1)

2022 (1)

• Hepatitis C antibody testing among opioid agonist therapy recipients, Victoria, Australia, 2012 to 2020.
  Dawe J, Wilkinson AL, Asselin J, Carter A, Pedrana A, Traeger MW, Thomas AJ, Curtis M, Cooper M, Howell J, Doyle JS, Hellard ME, Stoové M; EC Victoria Partnership and the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of blood borne viruses and sexually transmissible infections (ACCESS).
  Int J Drug Policy. 2022 Apr; 104:103696